News

October 22, 2007 – IVUS integrated on GE Healthcare’s X-ray cath lab imaging system cut procedure time by up to 40 percent when compared to procedures performed on another GE Healthcare Innova using Volcano’s S5 standalone IVUS system, according to a time-motion study conducted at Providence Heart Institute in Columbia, SC, and presented at TCT 2007.

Home October 24, 2007
Home
News

October 24, 2007 — Drug-eluting balloons could offer a viable alternative to drug-eluting stents (DES) in the treatment of coronary artery disease, according to research results from two studies presented today at TCT 2007, in which one of the studies marked the first direct comparison between DES and drug eluting balloons.

Home October 24, 2007
Home
News

October 25, 2007 - Early intervention saves lives in women who have a heart attack or unstable chest pain, according to research presented at TCT 2007, information that counters reports suggesting women do not fare as well as men following angioplasty.

Home October 24, 2007
Home
News

October 25, 2007 – Ceremed's Ostene, designed to stop bone bleeding in surgery, reportedly does not interfere with bone ...

Home October 24, 2007
Home
News

October 25, 2007 - Paieon Inc. demonstrated at TCT 2007 the CardiOp-StentOptimizer, a real-time imaging solution ...

Home October 24, 2007
Home
News

October 24, 2007 – ev3 Inc. highlighted at TCT 2007 its merger with FoxHollow Technologies, Inc., which created an organization that possesses one of the largest U.S. distribution footprints in endovascular devices with combined technologies for the advancement of the treatment of peripheral and neurovascular disease.

Home October 23, 2007
Home
News

October 23, 2007 – Patients who received the CYPHER Sirolimus-eluting coronary stent had a lower risk of stent ...

Home October 22, 2007
Home
News

October 22, 2007 – A time-motion study conducted at Providence Heart Institute in Columbia, SC, spanning approximately ...

Home October 22, 2007
Home
News

October 22, 2007 – At TCT 2007, ProSolv CardioVascular, a FUJIFILM company, (ProSolv) demonstrated its advanced ...

Home October 22, 2007
Home
News

October 23, 2007 – After 12 months of the SPIRIT III trial, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent, researchers reported at TCT 2007.

Home October 22, 2007
Home
News

October 23, 2007 - Toshiba America Medical Systems Inc. today announced that the first U.S. installation of the Infinix ...

Home October 22, 2007
Home
News

October 23, 2007 - ENDEAVOR IV reached its primary endpoint of target vessel failure non-inferiority when compared to ...

Home October 22, 2007
Home
News

OCTOBER 23, 2007 – Abbott’s fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease ...

Home October 22, 2007
Home
News

October 23, 2007 - PLC Systems Inc. introduced at TCT 2007 the RenalGuard System, an investigational system and therapy ...

Home October 22, 2007
Home
News

October 23, 2007 - Hologic Inc.

Home October 22, 2007
Home
Subscribe Now